AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 65 filers reported holding AURA BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $59,238 | +159.8% | 6,604 | +257.7% | 0.00% | +100.0% |
Q2 2023 | $22,798 | +227880.0% | 1,846 | +71.6% | 0.00% | – |
Q1 2023 | $10 | -73.0% | 1,076 | -69.6% | 0.00% | -100.0% |
Q4 2022 | $37 | -99.8% | 3,535 | +180.1% | 0.00% | – |
Q3 2022 | $23,000 | -58.9% | 1,262 | -68.0% | 0.00% | -100.0% |
Q2 2022 | $56,000 | +133.3% | 3,949 | +256.1% | 0.00% | – |
Q1 2022 | $24,000 | +118.2% | 1,109 | +68.5% | 0.00% | – |
Q4 2021 | $11,000 | – | 658 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $51,617,000 | 12.92% |
Matrix Capital Management Company, LP | 4,112,870 | $69,837,000 | 0.78% |
Rock Springs Capital Management LP | 1,008,114 | $17,118,000 | 0.40% |
Nantahala Capital Management | 99,146 | $1,683,000 | 0.06% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,255,480 | $21,318,000 | 0.04% |
Citadel Advisors | 2,315,102 | $37,318,000 | 0.01% |
CAAS CAPITAL MANAGEMENT LP | 10,000 | $170,000 | 0.00% |
Concord Wealth Partners | 150 | $3,000 | 0.00% |
Allianz Asset Management GmbH | 55,145 | $936,000 | 0.00% |
FMR LLC | 471,300 | $8,003,000 | 0.00% |